Evidence map›Paper›PMID 39541039›Full record

ReviewLasers in medical science2024

Current trends and advancements in utilizing endoscopic cyclophotocoagulation for the Treatment of Glaucoma.

Kuanrong Dang, Di Gong, Qing Zhang, Junhong Guo, Yijia Huang, Zihan Huang, Zhichao Yan, Xiaoli Shen, Jiantao Wang

Abstract readReview
PubMed Publisher
In one paragraph

Review in Lasers in medical science, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Kuanrong Dang *Shenzhen Eye Institute, Shenzhen Eye Hospital, Jinan University, Shenzhen, China.
Di Gong *Shenzhen Eye Institute, Shenzhen Eye Hospital, Jinan University, Shenzhen, China.
Qing Zhang *The Third Affiliated Hospital of Xinxiang Medical University, Xinxiang Medical University, Xinxiang, China.
Junhong GuoShenzhen Eye Institute, Shenzhen Eye Hospital, Jinan University, Shenzhen, China.
Yijia HuangShenzhen Eye Institute, Shenzhen Eye Hospital, Jinan University, Shenzhen, China.
Zihan HuangShenzhen Eye Institute, Shenzhen Eye Hospital, Jinan University, Shenzhen, China.
Zhichao YanShenzhen Eye Institute, Shenzhen Eye Hospital, Jinan University, Shenzhen, China.
Xiaoli ShenShenzhen Eye Institute, Shenzhen Eye Hospital, Jinan University, Shenzhen, China.
Jiantao WangShenzhen Eye Institute, Shenzhen Eye Hospital, Jinan University, Shenzhen, China. wangjiantao65@126.com.

Funding

National Key Clinical Specialty Discipline Construction Program of China 82070961Project of High-level Teachers in Beijing Municipal Universities in the Period of 13th Five-year Plan SZSM202311012Science, Technology and Innovation Commission of Shenzhen Municipality JCYJ20220530153415034Science, Technology and Innovation Commission of Shenzhen Municipality JCYJ20220818103207015Shenzhen Fund for Guangdong Provincial High-level Clinical Key Specialties SZGSP014
6 · The paper itself

Abstract

Glaucoma ranks as the second most prevalent cause of global blindness. Presently, the reduction of intraocular pressure (IOP) stands as the sole efficacious method for addressing this condition. Endoscopic cyclophotocoagulation (ECP) is designed to mitigate aqueous humor production by inducing coagulation or closure of the ciliary body. Since its inception in 1990s, ECP has emerged as a pivotal modality in the therapeutic armamentarium for glaucoma. This review primarily elucidates the instrumentation employed in ECP for the treatment of glaucoma, the mechanisms underlying its efficacy in glaucoma management, and a comparative analysis of ECP in relation to other modalities for anti-glaucoma treatment. Furthermore, it examines the contemporary clinical utilization of ECP in glaucoma therapy, as well as the prevalent postoperative complications and their preventive measures. We anticipate that the role of ECP in the treatment of glaucoma will persistently evolve alongside advancements in the field. Particularly noteworthy is its expanding applicability in glaucoma therapy and its increasingly vital role in personalized comprehensive treatment approaches.

Indexed as

Ciliary BodyEndoscopyGlaucomaIntraocular PressureLaser CoagulationHumansCiliary bodyEndoscopic cyclophotocoagulation (ECP)GlaucomaIntraocular pressure (IOP)Laser

Identifiers

PMID39541039

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.